Endocrinology, Vol 120, 115-123, Copyright © 1987 by Endocrine Society

ARTICLES

The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor

DZ Ewton, SL Falen and JR Florini

We have characterized binding and several actions of the somatomedins [insulin-like growth factors I and II (IGF-I and IGF-II)] on L6 myoblasts. Both IGF-I and IGF-II are potent stimulators of amino acid uptake, cell proliferation, and differentiation; they also suppress protein degradation in these cells. In all measurements, the relative potencies are IGF-I greater than IGF-II greater than insulin. Two recombinant DNA-produced analogs of IGF-I, (Thr59)IGF-I and (N-Met)IGF- I, were as active as native IGF-I in all four assays. However, when 125I-labeled hormones were used for studies of binding to IGF receptors, there was a striking difference between the native and recombinant IGF-I molecules. Both were bound significantly by the type I receptor (a 350K molecule that is dissociated upon sulfhydryl reduction), but the recombinant analogs exhibited little cross- reactivity with the type II receptor (a 220K molecule that is not dissociated by reduction). Thus, the equal activity of native IGF-I and its recombinant DNA-produced analogs coupled with the higher potency of IGF-I (compared to IGF-II) suggest that the type II receptor plays little or no role in the four actions of the somatomedins studied in L6 myoblasts.

This article has been cited by other articles:

				K. Van den Maagdenberg, E. Claeys, A. Stinckens, N. Buys, and S. De Smet Effect of age, muscle type, and insulin-like growth factor-II genotype on muscle proteolytic and lipolytic enzyme activities in boars J Anim Sci, April 1, 2007; 85(4): 952 - 960. [Abstract] [Full Text] [PDF]

				J. Castillo, M. Codina, M. L. Martinez, I. Navarro, and J. Gutierrez Metabolic and mitogenic effects of IGF-I and insulin on muscle cells of rainbow trout Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R935 - R941. [Abstract] [Full Text] [PDF]

				S. P. Kirk, J. M. Oldham, F. Jeanplong, and J. J. Bass Insulin-like Growth Factor-II Delays Early but Enhances Late Regeneration of Skeletal Muscle J. Histochem. Cytochem., December 1, 2003; 51(12): 1611 - 1620. [Abstract] [Full Text] [PDF]

				M. Carrasco, J. Canicio, M. Palacin, A. Zorzano, and P. Kaliman Identification of Intracellular Signaling Pathways that Induce Myotonic Dystrophy Protein Kinase Expression during Myogenesis Endocrinology, August 1, 2002; 143(8): 3017 - 3025. [Abstract] [Full Text] [PDF]

				S. Adi, B. Bin-Abbas, N.-Y. Wu, and S. M. Rosenthal Early Stimulation and Late Inhibition of Extracellular Signal-Regulated Kinase 1/2 Phosphorylation by IGF-I: A Potential Mechanism Mediating the Switch in IGF-I Action on Skeletal Muscle Cell Differentiation Endocrinology, February 1, 2002; 143(2): 511 - 516. [Abstract] [Full Text] [PDF]

				M. Fournier and M. I. Lewis Influences of IGF-I gene disruption on the cellular profile of the diaphragm Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E707 - E715. [Abstract] [Full Text] [PDF]

				K. L. Haugk, H.-M. P. Wilson, K. Swisshelm, and L. S. Quinn Insulin-Like Growth Factor (IGF)-Binding Protein-Related Protein-1: An Autocrine/Paracrine Factor That Inhibits Skeletal Myoblast Differentiation but Permits Proliferation in Response to IGF Endocrinology, January 1, 2000; 141(1): 100 - 110. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, X. Testar, M. Palacin, and A. Zorzano Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-kappa B and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway J. Biol. Chem., June 18, 1999; 274(25): 17437 - 17444. [Abstract] [Full Text] [PDF]

				D. D. Sarbassov, L. G. Jones, and C. A. Peterson Extracellular Signal-Regulated Kinase-1 and -2 Respond Differently to Mitogenic and Differentiative Signaling Pathways in Myoblasts Mol. Endocrinol., December 1, 1997; 11(13): 2038 - 2047. [Abstract] [Full Text] [PDF]

				S. A. Coolican, D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways J. Biol. Chem., March 7, 1997; 272(10): 6653 - 6662. [Abstract] [Full Text] [PDF]

				P. Kaliman, F. Vinals, X. Testar, M. Palacin, and A. Zorzano Phosphatidylinositol 3-Kinase Inhibitors Block Differentiation of Skeletal Muscle Cells J. Biol. Chem., August 9, 1996; 271(32): 19146 - 19151. [Abstract] [Full Text] [PDF]

				R. Roth Structure of the receptor for insulin-like growth factor II: the puzzle amplified Science, March 11, 1988; 239(4845): 1269 - 1271. [Abstract] [PDF]

				J. Canicio, P. Ruiz-Lozano, M. Carrasco, M. Palacin, K. Chien, A. Zorzano, and P. Kaliman Nuclear Factor kappa B-inducing Kinase and Ikappa B Kinase-alpha Signal Skeletal Muscle Cell Differentiation J. Biol. Chem., June 1, 2001; 276(23): 20228 - 20233. [Abstract] [Full Text] [PDF]